Paclitaxel and BKM120 Before Surgery in Treating Patients With Stage II or III Estrogen Receptor-Positive and HER2-Negative Breast Cancer

NCT01953445 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped The study sponsor found the trial to be not viable.

Conditions

Breast Neoplasms

Interventions

DRUG: paclitaxel
DRUG: BKM120

Sponsor

Washington University School of Medicine